ABIONYX Pharma Market Cap

ABIONYX Pharma has a market cap or net worth of €115.18 million as of March 13, 2026. Its market cap has increased by 158.29% in one year.

Market Cap

115.18M

Enterprise Value

115.93M

Revenue

4.10M

Ranking

n/a

PE Ratio

n/a

Stock Price

€3.27

Market Cap Chart

Since March 30, 2015, ABIONYX Pharma's market cap has decreased from 214.16M to 115.18M, a decrease of -46.22%. That is a compound annual growth rate of -5.50%.

Market Cap History

Date	Market Cap	% Change
Mar 13, 2026	115.18M	-13.74%
Dec 31, 2025	133.53M	223.58%
Dec 31, 2024	41.27M	-0.54%
Dec 29, 2023	41.49M	-14.37%
Dec 30, 2022	48.45M	-28.38%
Dec 31, 2021	67.65M	178.53%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Cellectis	227.82M
Transgene	213.59M
Sensorion	198.23M
MaaT Pharma	129.46M
Innate Pharma	117.16M
Adocia	116.19M
OSE Immunotherapeutics	82.51M
Valerio Therapeutics Société anonyme	65.99M

Market Cap Rankings